X0306 4 2019-08-16 0 0001466301 Clovis Oncology, Inc. CLVS 0001024000 BLAIR JAMES C C/O DOMAIN ASSOCIATES, LLC 202 CARNEGIE CENTER, SUITE 104 PRINCETON NJ 08540 1 0 0 0 Common Stock 2019-08-16 4 P 0 20000 5.70 A 33439 D Common Stock 2019-08-20 4 P 0 20000 5.97 A 20000 I By wife Common Stock 10105 I By Susan W. and James C. Blair Family LP. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.65 to $5.73. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.88 to $6.09. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The Reporting Person disclaims beneficial ownership of such shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose. The Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. The transaction reported herein inadvertently resulted in a short swing profit of approximately $461 under Section 16(b) of the Securities Exchange Act of 1934, as amended ("Section 16(b)"). The Issuer has made arrangements with the Reporting Person to disgorge short swing profits realized to the Issuer, and upon settlement, the Reporting Person will have discharged in full any obligation under Section 16(b) with respect to the reported transactions. /s/ James C. Blair 2019-08-19